ViaCyte's Sweet Three-Pronged Attack against Type 1 Diabetes
ViaCyte (@ViaCyte) / Twitter
ViaCyte's Future 'Functional Diabetes Cure' for Diabetes
Will ViaCyte's Encaptra Cell Delivery System 'Cure' Type 1 Diabetes? | Insulin Nation
Diabetes Stem Cell Milestone: ViaCyte Transplants 1st Patient - The Niche
ViaCyte & CRISPR Therapeutics team up to battle diabetes - The Niche
ViaCyte | Regenerative Medicine Therapies for Diabetes
Filming the ViaCyte Type 1 Cell Experiment | Insulin Nation
ViaCyte and CRISPR Introduce New Stem Cell Therapy for Type 1 Diabetes
ViaCyte | Regenerative Medicine Therapies for Diabetes
Product Pipeline for Insulin-Requiring Diabetes Treatments
Producing insulin for people who can't | The Stem Cellar
Product Pipeline for Insulin-Requiring Diabetes Treatments
San Diego biotech working on 'functional cure' for type 1 diabetes sold to rival for $320M - The San Diego Union-Tribune
JDRF Applauds the Small Business Innovative Research Award to ViaCyte
Gore joins ViaCyte's quest for a functional type 1 diabetes cure - MedCity News
ViaCyte (@ViaCyte) / Twitter
Stem Cell Implants Could Cure Diabetes | Healthcare Packaging
Product Pipeline for Insulin-Requiring Diabetes Treatments
ViaCyte and Gore Expand Collaboration to Develop Novel Membrane and Device Technologies that Enhance Delivery of Cell Replacement Therapies for Diabetes
ViaCyte (@ViaCyte) / Twitter
ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes | Bain Capital
ViaCyte | Regenerative Medicine Therapies for Diabetes
ViaCyte (@ViaCyte) / Twitter
ViaCyte Advances Cell Replacement Therapy for High Risk Type 1 Diabetes | The Stem Cellar
